HomeVTGN • NASDAQ
add
Vistagen Therapeutics Inc
Previous close
$2.03
Day range
$1.99 - $2.07
Year range
$1.90 - $4.20
Market cap
59.77M USD
Avg Volume
189.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | -15.00K | -107.61% |
Operating expense | 14.48M | 25.30% |
Net income | -13.64M | -43.21% |
Net profit margin | 90.90K | 1,980.82% |
Earnings per share | -0.44 | -76.00% |
EBITDA | -14.46M | -27.63% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 80.48M | -32.46% |
Total assets | 84.34M | -31.79% |
Total liabilities | 13.95M | 48.94% |
Total equity | 70.39M | — |
Shares outstanding | 29.16M | — |
Price to book | 0.84 | — |
Return on assets | -41.03% | — |
Return on capital | -46.84% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -13.64M | -43.21% |
Cash from operations | -10.06M | -44.05% |
Cash from investing | 527.00K | 1,917.24% |
Cash from financing | 1.95M | 613.42% |
Net change in cash | -7.58M | -2.57% |
Free cash flow | -5.64M | -3.12% |
About
Founded
1998
Headquarters
Website
Employees
57
